Please login to the form below
Lupin appoints Thierry Volle president for EMEA
He moves to the company from Vifor
Mumbai-based pharma company Lupin has appointed Thierry Volle to lead its Europe, Middle-East and Africa operations as president.
Volle will be responsible for the company's growth and development in Europe, Russia and CIS, as well as the Middle-East and African markets, and he will be based at Lupin's European headquarters in Zug, Switzerland.
He joins the firm from Vifor Pharma, where he was the head of EU and International business operations, and prior to that he served at Wyeth.
Vinita Gupta, Lupin's chief executive officer, said: "We are delighted to have Thierry join the Lupin family. His rich knowledge and experience in developing and growing businesses, specifically specialty pharmaceuticals in EMEA, will help us with our strategic expansion plans for these markets."
Featured jobs
- Senior Account Director or Business Unit Director, Healthcare Ad...
-
C£60, 000 – £70, 000 benefits
- Senior Strategic Planner, Healthcare Brand Communications, Londo...
-
Competitive Salary
- Account Director, Training & Medical Communications, London
-
Competitive Salary
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
- Senior Medical Writer, MedComms Agency
-
£40 - 55, 000 according to skills and experience benefits
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
- Science Writer – Healthcare Advertising
-
Salary TBC
- Medical Writer, Healthcare Advertising
-
£35 - £45, 000 benefits
-
Scientific Engagement Director
-
Salary will be dependant on experience
- Multi-Channel Account Managers - Road / Home-office based – Full...
-
Competitive salary
-
Account Manager
-
£40, 000 - £45, 000 benefits
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
- Medical Writer - Medical Communications
-
£30, 000 - £40, 000 according to skills and experience plus benefits
Subscribe to our email news alerts
- Roche starts new late-stage trials of Alzheimer’s candidate
- AbbVie, Roche get FDA OK for broader use of Venclexta
- Moving annual total (MAT)
- UK pharma cheers EU science announcement
- AbbVie builds case for arthritis blockbuster-in-waiting upadacitinib
- Daily Brief: Tagrisso's first line approval, EULAR and EHA, and why Stephen Hawking was wrong on NHS
- How can pharma build bridges with HCPs online?
- NICE set to reject Kyowa Kirin’s Crysvita for XLH
- More impressive data from Bluebird’s gene therapy in thalassemia and sickle cell disease
- UK firm Nightstar bags FDA fast-track status for gene therapy
- British Business Bank sets up £2.5bn fund for ‘unicorn’ firms
- Commentary: Roseanne’s racist tweet and Sanofi’s swift and surprising riposte
PMHub
Page & Page
Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...
Latest intelligence
- Australian Flu and the dilemma of naming diseases
- ...
- Wearables and Healthcare
- What place do wearables have in affecting actual patient health outcomes and can they contribute to the NHS’s sustainability agenda? Or are they just the latest fad?...
- What does a future-proof rep look like?
- Businesses can no longer afford to push ahead with the traditional Key Account Management model....
Quick links
Infographics
